Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Amandine Decroos"'
Autor:
Amandine Decroos, Sarah Meddour, Marine Demoy, Nathalie Piccirilli, Philippe Rousselot, Franck E. Nicolini, Stéphanie Ragot, Jean-Marc Gombert, André Herbelin, Alice Barbarin, Emilie Cayssials
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Considering the general view that unconventional immune effectors play a major role in antitumor immunity, we recently postulated that the distinct new innate CD8 T-cell pool (co-expressing the transcription factor Eomesodermin and innate markers suc
Externí odkaz:
https://doaj.org/article/bfad382e614a4f12abe94c7ae4501171
Autor:
Amandine Decroos, Morgane Cheminant, Julie Bruneau, Sylvain Carras, Vincent Parinet, Laura Pelletier, Laetitia Lacroix, Nadine Martin, Jérôme Giustiniani, Ludovic Lhermitte, Vahid Asnafi, Maxime Battistella, François Lemonnier, Laurence de Leval, Hélène Sicard, Cécile Bonnafous, Laurent Gauthier, Laurent Genestier, Stefano Caruso, Philippe Gaulard, Olivier Hermine, Nicolas Ortonne
Publikováno v:
Haematologica, Vol 108, Iss 10 (2023)
Externí odkaz:
https://doaj.org/article/35503a6abe54496780398ceaf85da27c
Autor:
Jérôme Giustiniani, Laura Pelletier, Philippe Gaulard, Amandine Decroos, Nicolas Ortonne, Saskia Ingen-Housz-Oro
Publikováno v:
European journal of cancer (Oxford, England : 1990). 156
Autor:
Philippe Gaulard, Saskia Ingen-Housz-Oro, Amandine Decroos, Laura Pelletier, Nicolas Ortonne, Jérôme Giustiniani
Publikováno v:
Annales de Dermatologie et de Vénéréologie. 147:A152
Introduction PD1 est souvent exprime par les cellules tumorales du syndrome de Sezary (SS). Dans un modele murin de lymphome T (ITK-SYK), il a ete montre que PD1 pourrait jouer un role suppresseur de tumeur haplo-insuffisant. Cela pourrait expliquer
Autor:
Florence Orlanducci, Armand Bensussan, Philippe Gaulard, Martine Bagot, Rémy Castellano, Nicolas Ortonne, Armelle Goubard, Laurent Gorvel, Amandine Decroos, Florent Amatore, Daniel Olive, Jean-Jacques Grob, Philippe Berbis, Saskia Ingen-Housz-Oro, Reda Bouabdallah, N. Bonnet, Marc Lopez
Publikováno v:
Journal of Clinical Oncology. 38:e20040-e20040
e20040 Background: Advanced stage cutaneous T-cell lymphomas (CTCLs) remain an unmet medical need. Immunomodulatory agents such as mogamulizumab, anti-KIR3DL2 and brentuximab vedotin (BV), an anti-CD30 antibody–drug conjugate (ADC) coupled to monom
Autor:
Moran, Galperin, Carine, Farenc, Madhura, Mukhopadhyay, Dhilshan, Jayasinghe, Amandine, Decroos, Daniela, Benati, Li Lynn, Tan, Lisa, Ciacchi, Hugh H, Reid, Jamie, Rossjohn, Lisa A, Chakrabarti, Stephanie, Gras
Publikováno v:
Science immunology. 3(24)
Rare individuals, termed HIV controllers, spontaneously control HIV infection by mounting efficient T cell responses against the virus. Protective CD4
Autor:
Daniela Benati, Moran Galperin, Jamie Rossjohn, Lisa Ciacchi, Amandine Decroos, Lisa A. Chakrabarti, Hugh H. Reid, Dhilshan Jayasinghe, Stephanie Gras, Madhura Mukhopadhyay, Li Lynn Tan, C. Farenc
Publikováno v:
Science Immunology
Science Immunology, American Association for the Advancement of Science, 2018, 3 (24), pp.eaat0687. ⟨10.1126/sciimmunol.aat0687⟩
Science Immunology, 2018, 3 (24), pp.eaat0687. ⟨10.1126/sciimmunol.aat0687⟩
Science Immunology, American Association for the Advancement of Science, 2018, 3 (24), pp.eaat0687. ⟨10.1126/sciimmunol.aat0687⟩
Science Immunology, 2018, 3 (24), pp.eaat0687. ⟨10.1126/sciimmunol.aat0687⟩
International audience; Rare individuals, termed HIV controllers, spontaneously control HIV infection by mounting efficient T cell responses against the virus. Protective CD4+ T cell responses from HIV controllers involve high-affinity public T cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b1364c6d98ab51af27681c72e4a2ec1
https://hdl.handle.net/11380/1169081
https://hdl.handle.net/11380/1169081